Cohort Construction and Prognostic Model Construction for Multiple Myeloma

Soochow University

Status: Active, not recruiting

Conditions: Multiple Myeloma

Study type: Observational

Funder types: Other

Identifiers

NCT06366802

Prognosis model-MM09

Details and patient eligibility

About

Multiple myeloma (MM) is a disease caused by malignant plasma cell proliferation disorder. Survival outcomes continue to vary widely even within uniformly treated clinical trial populations. How to construct a clinical prognosis model of MM through real-world data to guide the selection of treatment options, standardize patient management, and improve survival expectations, is a major problem that needs to be solved urgently. It is necessary to build an MM-specific cohort in China to comprehensively understand the characteristics of MM patients, explore treatment options, and improve prognostic factors for survival outcomes.

Enrollment: 1,000 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

Patients were diagnosed as multiple myeloma from January 1, 2008 (the diagnostic criteria are based on "Chinese Guidelines for the Diagnosis and Treatment of Multiple Myeloma (Revised in 2020)").

Exclusion criteria

Long-term follow-up information for patients is not available for any reason, such as not being available or having a serious concomitant disease.